Simplex Castings Gets BSE In-Principle Nod for ₹99.71 Crore Issue

Simplex Castings Limited received BSE Limited's in-principle approval on November 3, 2026, for a preferential issue with a maximum value of ₹99.71 crore at ₹105 per security. The clearance covers 44.91 lakh equity shares and 50.05 lakh convertible warrants, but it does not confirm allotment, warrant conversion or listing.

What did BSE approve for Simplex Castings?

BSE approved in principle Simplex Castings' proposal to issue up to 44,90,791 equity shares and 50,05,195 convertible warrants on a preferential basis. The approval was disclosed by the company on November 3, 2026, after shareholders had approved the relevant resolutions at an extraordinary general meeting held on October 15, 2026.

The exchange's clearance is an intermediate regulatory step rather than approval for the new securities to begin trading. The company has stated that BSE's approval does not amount to listing approval for either the direct equity shares or the convertible warrants. Allotment, subsequent compliance filings and listing formalities remain to be completed.

The proposed issue price is not less than ₹105 per equity share or warrant. At that price, the direct equity-share component has an aggregate value of about ₹47.15 crore, while the warrant component represents about ₹52.55 crore if fully subscribed and converted. Together, the planned fund raise is stated at approximately ₹99.71 crore.

How is the preferential issue structured?

The proposed preferential issue consists of 44.91 lakh equity shares for non-promoter investors and 50.05 lakh warrants for promoter and non-promoter investors. Each warrant is convertible into one equity share, meaning the warrant portion could result in 50.05 lakh additional shares if every warrant is exercised.

The aggregate figure of 94.96 lakh securities combines the directly proposed equity shares with the potential equity shares arising upon full warrant conversion. It should not be treated as confirmation that 94.96 lakh equity shares have been allotted, or that all such shares will be listed at the same time.

The warrants can be exercised within 18 months from their allotment, according to the shareholder-approved terms disclosed by the company. Therefore, the warrant amount represents potential equity capital, subject to allotment and subsequent exercise by warrant holders, rather than equity shares already issued.

What has happened before the BSE clearance?

The fund-raising proposal was considered by the board of Simplex Castings on September 23, 2026, subject to shareholder and regulatory approvals. The board also approved an increase in authorised share capital from ₹10 crore to ₹15 crore, creating capacity for the proposed securities.

Shareholders approved the preferential issue through special resolutions at the October 15, 2026 extraordinary general meeting conducted through video conferencing. The resolutions covered the issue of 44,90,791 equity shares to non-promoters and 50,05,195 warrants to promoter and non-promoter investors.

The disclosed allottee information identifies several non-promoter participants in the equity and warrant proposals. For the warrant issue, promoter Ketan Moolchand Shah is identified as the largest allottee. The company disclosures also show that his percentage holding would move from 37.44% to 32.28% after conversion, reflecting the effect of the broader proposed equity base.

The sequence set out in the BSE communication remains important for investors. Simplex Castings must first complete the required compliance process and allot the securities. It must then submit its listing application within 20 days from the allotment date, followed by completion of listing formalities.

What does the approval mean for investors and the company?

The BSE approval advances the proposed capital raise but does not establish that the company has received the full ₹99.71 crore. The direct equity-share issue and the warrants remain subject to allotment, while the warrant proceeds depend on conversion by holders within the permitted period.

For existing shareholders, the proposal may increase the outstanding equity base when the direct shares are allotted and again if warrants are converted. The disclosures provide post-issue holding illustrations for named allottees, but the actual capital structure will depend on the allotment and conversion process being completed.

The proposal was made in the context of a planned fund raise for the company's heavy engineering operations. However, the November 3 disclosure is specifically a report of exchange clearance, not a disclosure of completed deployment of funds, completed allotment or a final listing date.

Investors should distinguish between in-principle approval and listing approval when assessing the announcement. The immediate confirmed development is BSE's clearance for the proposed issue structure at a minimum price of ₹105, while the timing of allotment, conversion and listing has not been provided in the filing.

Conclusion

Simplex Castings has secured an important exchange clearance for its proposed ₹99.71 crore preferential issue, comprising 44.91 lakh direct equity shares and 50.05 lakh convertible warrants. The approval supports the proposed fundraising process, but the 94.96 lakh combined figure includes potential shares from warrant conversion and is not evidence of completed issuance or listing.

The next disclosed milestone is allotment of the equity shares and warrants. After allotment, Simplex Castings is required to submit a listing application to BSE within 20 days, while warrant holders may exercise their conversion rights within 18 months from allotment.